Dr. Anthony Fauci of the National Institute of Health is scrutinized for his dual role in HIV/AIDS research and the current Ebola response. Adam Curry highlights Fauci's ownership of an overarching IL-2 antiviral patent. The hosts question the connection between his past work on immune deficiency and the rapid development of an Ebola vaccine for human trials.
